Skip to main content
Erschienen in: International Journal of Legal Medicine 1/2018

11.05.2017 | Original Article

Early markers of myocardial ischemia: from the experimental model to forensic pathology cases of sudden cardiac death

verfasst von: Sara Sabatasso, Milena Moretti, Patrice Mangin, Tony Fracasso

Erschienen in: International Journal of Legal Medicine | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Abstract

The goal of this study was to assess whether early markers of myocardial ischemia, identified in a previous experimental work, can be applied in forensic pathology cases of sudden, ischemic cardiac death. These markers include desphosphorylated connexin 43 (Cx43), JunB, TUNEL assay, myoglobin, and troponin T. Fourteen cases of sudden cardiac death with gross and/or histological signs of myocardial infarction and 14 cases of sudden cardiac death with signs of early ischemia at histology and positive immunoreactions for fibronectin and C5b-9 were investigated. The control group was represented by 15 hanging (global hypoxia) cases. Immunohistochemical reactions were classified into four degrees and compared among groups. Cx43 and JunB were significantly more expressed in hanging than in ischemia/infarction, but they showed a different distribution in the tissue (sub-endocardial in ischemia/infarction, diffuse in hanging) and a different intensity of the signal. TUNEL assay was significantly more expressed in the group of early ischemia than in myocardial infarction. Myoglobin and troponin T did not show any significantly different expression among the three groups. Depletion markers have a limited application in forensic cases, and this is mostly because positive (depleted) areas are difficult to distinguish from artifactually paler areas. Nuclear markers (JunB and TUNEL), on the other hand, require a well-trained eye and a high magnification in order to be distinguished. Cx43, JunB, and TUNEL assays were confirmed to be early, sensitive markers for myocardial ischemia. Nonetheless, they are not specific, as they are expressed in global hypoxia as well, but with a different tissular distribution.
Literatur
1.
Zurück zum Zitat Sabatasso S, Mangin P, Fracasso T et al (2016) Early markers for myocardial ischemia and sudden cardiac death. Int J Legal Med 130(5):1265–1280PubMedCrossRef Sabatasso S, Mangin P, Fracasso T et al (2016) Early markers for myocardial ischemia and sudden cardiac death. Int J Legal Med 130(5):1265–1280PubMedCrossRef
2.
Zurück zum Zitat Campobasso CP, Dell’Erba AS, Addante A et al (2008) Sudden cardiac death and myocardial ischemia indicators: a comparative study of four immunohistochemical markers. Am J Forensic Med Pathol 29:154–161PubMedCrossRef Campobasso CP, Dell’Erba AS, Addante A et al (2008) Sudden cardiac death and myocardial ischemia indicators: a comparative study of four immunohistochemical markers. Am J Forensic Med Pathol 29:154–161PubMedCrossRef
3.
Zurück zum Zitat Fracasso T, Karger B, Pfeiffer H et al (2010) Immunohistochemical identification of prevalent right ventricular ischemia causing right heart failure in cases of pulmonary fat embolism. Int J Legal Med 124:537–542PubMedCrossRef Fracasso T, Karger B, Pfeiffer H et al (2010) Immunohistochemical identification of prevalent right ventricular ischemia causing right heart failure in cases of pulmonary fat embolism. Int J Legal Med 124:537–542PubMedCrossRef
4.
Zurück zum Zitat Fracasso T, Pfeiffer H, Sauerland C et al (2011) Morphological identification of right ventricular failure in cases of fatal pulmonary thromboembolism. Int J Legal Med 125:45–50PubMedCrossRef Fracasso T, Pfeiffer H, Sauerland C et al (2011) Morphological identification of right ventricular failure in cases of fatal pulmonary thromboembolism. Int J Legal Med 125:45–50PubMedCrossRef
5.
Zurück zum Zitat Haitao B, Ying Y, Jianye H et al (2013) Immunohistochemical detection of S100A1 in the postmortem diagnosis of acute myocardial infarction. Diagn Pathol 8:84 Haitao B, Ying Y, Jianye H et al (2013) Immunohistochemical detection of S100A1 in the postmortem diagnosis of acute myocardial infarction. Diagn Pathol 8:84
6.
Zurück zum Zitat Willems I, Arends JW, Daemen M (1996) Tenascin and fibronectin expression in healing human myocardial scars. J Pathol 179:321–325PubMedCrossRef Willems I, Arends JW, Daemen M (1996) Tenascin and fibronectin expression in healing human myocardial scars. J Pathol 179:321–325PubMedCrossRef
7.
Zurück zum Zitat Ortmann C, Pfeiffer H, Brinkmann B (2000) A comparative study on the immunohistochemical detection of early myocardial damage. Int J Legal Med 113(4):215–220PubMedCrossRef Ortmann C, Pfeiffer H, Brinkmann B (2000) A comparative study on the immunohistochemical detection of early myocardial damage. Int J Legal Med 113(4):215–220PubMedCrossRef
8.
Zurück zum Zitat Shekhonin BV, Guriev SB, Irgashev SB et al (1990) Immunofluorescent identification of fibronectin and fibrinogen/fibrin in experimental myocardial infarction. J Mol Cell Cardiol 22(5):533–541PubMedCrossRef Shekhonin BV, Guriev SB, Irgashev SB et al (1990) Immunofluorescent identification of fibronectin and fibrinogen/fibrin in experimental myocardial infarction. J Mol Cell Cardiol 22(5):533–541PubMedCrossRef
9.
Zurück zum Zitat Casscells W, Kimura H, Sanchez JA et al (1990) Immunohistochemical study of fibronectin in experimental myocardial infarction. Am J Pathol 137(4):801–810PubMedPubMedCentral Casscells W, Kimura H, Sanchez JA et al (1990) Immunohistochemical study of fibronectin in experimental myocardial infarction. Am J Pathol 137(4):801–810PubMedPubMedCentral
10.
Zurück zum Zitat Hu BJ, Chen YC, Zhu JZ (1996) Immunohistochemical study of fibronectin for postmortem diagnosis of early myocardial infarction. Forensic Sci Int 78(3):209–217PubMedCrossRef Hu BJ, Chen YC, Zhu JZ (1996) Immunohistochemical study of fibronectin for postmortem diagnosis of early myocardial infarction. Forensic Sci Int 78(3):209–217PubMedCrossRef
11.
Zurück zum Zitat Hu BJ, Chen YC, Zhu JZ (2002) Study on the specificity of fibronectin for post-mortem diagnosis of early myocardial infarction. Med Sci Law 42(3):195–199PubMedCrossRef Hu BJ, Chen YC, Zhu JZ (2002) Study on the specificity of fibronectin for post-mortem diagnosis of early myocardial infarction. Med Sci Law 42(3):195–199PubMedCrossRef
12.
Zurück zum Zitat Piercecchi-Marti MD, Lepidi H, Leonetti G et al (2001) Immunostaining by complement C9: a tool for early diagnosis of myocardial infarction and application in forensic medicine. J Forensic Sci 46(2):328–334PubMedCrossRef Piercecchi-Marti MD, Lepidi H, Leonetti G et al (2001) Immunostaining by complement C9: a tool for early diagnosis of myocardial infarction and application in forensic medicine. J Forensic Sci 46(2):328–334PubMedCrossRef
13.
Zurück zum Zitat Edston E, Kawa K (1995) Immunohistochemical detection of early myocardial infarction: an evaluation of antibodies against the terminal complement complex (C5b-9). Int J Legal Med 108(1):27–30PubMedCrossRef Edston E, Kawa K (1995) Immunohistochemical detection of early myocardial infarction: an evaluation of antibodies against the terminal complement complex (C5b-9). Int J Legal Med 108(1):27–30PubMedCrossRef
14.
Zurück zum Zitat Schäfer H, Mathey D, Hugo F et al (1986) Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium. J Immunol 137(6):1945–1949PubMed Schäfer H, Mathey D, Hugo F et al (1986) Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium. J Immunol 137(6):1945–1949PubMed
15.
Zurück zum Zitat Ortiz-Rey JA, Suarez-Penaranda JM, Da Silva EA et al (2002) Immunohistochemical detection of fibronectin and tenascin in incised human skin injuries. Forensic Sci Int 126(2):118–122PubMedCrossRef Ortiz-Rey JA, Suarez-Penaranda JM, Da Silva EA et al (2002) Immunohistochemical detection of fibronectin and tenascin in incised human skin injuries. Forensic Sci Int 126(2):118–122PubMedCrossRef
16.
Zurück zum Zitat Knowlton AA, Connelly CM, Romo GM et al (1992) Rapid expression of fibronectin in the rabbit heart after myocardial infarction with and without reperfusion. J Clin Invest 89(4):1060–1068PubMedPubMedCentralCrossRef Knowlton AA, Connelly CM, Romo GM et al (1992) Rapid expression of fibronectin in the rabbit heart after myocardial infarction with and without reperfusion. J Clin Invest 89(4):1060–1068PubMedPubMedCentralCrossRef
17.
Zurück zum Zitat Thomsen H, Schulz A, Bhakdi S (1990) Immunohistochemical C5b-9-complement complex demonstration in early stages of myocardial necroses using paraffin sections. Z Rechtsmed 103(3):199–206PubMedCrossRef Thomsen H, Schulz A, Bhakdi S (1990) Immunohistochemical C5b-9-complement complex demonstration in early stages of myocardial necroses using paraffin sections. Z Rechtsmed 103(3):199–206PubMedCrossRef
18.
Zurück zum Zitat Väkevä A, Morgan BP, Tikkanen I et al (1994) Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium. Am J Pathol 144(6):1357–1368PubMedPubMedCentral Väkevä A, Morgan BP, Tikkanen I et al (1994) Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium. Am J Pathol 144(6):1357–1368PubMedPubMedCentral
19.
Zurück zum Zitat Edston E, Gröntoft L, Johnsson J (2002) TUNEL: a useful screening method in sudden cardiac death. Int J Legal Med 116:22–26PubMedCrossRef Edston E, Gröntoft L, Johnsson J (2002) TUNEL: a useful screening method in sudden cardiac death. Int J Legal Med 116:22–26PubMedCrossRef
20.
Zurück zum Zitat Bardales RH, Hailey LS, Xie SS et al (1996) In situ apoptosis assay for the detection of early acute myocardial infarction. Am J Pathol 149(3):821–829PubMedPubMedCentral Bardales RH, Hailey LS, Xie SS et al (1996) In situ apoptosis assay for the detection of early acute myocardial infarction. Am J Pathol 149(3):821–829PubMedPubMedCentral
21.
Zurück zum Zitat Jugdutt BI, Idikio HA (2005) Apoptosis and oncosis in acute coronary syndromes: assessment and implications. Mol Cell Biochem 270(1–2):177–200PubMedCrossRef Jugdutt BI, Idikio HA (2005) Apoptosis and oncosis in acute coronary syndromes: assessment and implications. Mol Cell Biochem 270(1–2):177–200PubMedCrossRef
22.
Zurück zum Zitat Takemura G, Fujiwara H (2006) Morphological aspects of apoptosis in heart diseases. J Cell Mol Med 10(1):56–75PubMedCrossRef Takemura G, Fujiwara H (2006) Morphological aspects of apoptosis in heart diseases. J Cell Mol Med 10(1):56–75PubMedCrossRef
23.
Zurück zum Zitat Piro FR, di Gioia CR, Gallo P et al (2000) Is apoptosis a diagnostic marker of acute myocardial infarction? Arch Pathol Lab Med 124:827–831PubMed Piro FR, di Gioia CR, Gallo P et al (2000) Is apoptosis a diagnostic marker of acute myocardial infarction? Arch Pathol Lab Med 124:827–831PubMed
24.
Zurück zum Zitat Abbate A, Melfi R, Patti G et al (2000) Apoptosis in recent myocardial infarction. Clin Ter 151:247–251PubMed Abbate A, Melfi R, Patti G et al (2000) Apoptosis in recent myocardial infarction. Clin Ter 151:247–251PubMed
25.
Zurück zum Zitat Rodríguez-Calvo MS, Tourret MN, Concheiro L et al (2001) Detection of apoptosis in ischemic heart: usefulness in the diagnosis of early myocardial injury. Am J Forensic Med Pathol 22:278–284PubMedCrossRef Rodríguez-Calvo MS, Tourret MN, Concheiro L et al (2001) Detection of apoptosis in ischemic heart: usefulness in the diagnosis of early myocardial injury. Am J Forensic Med Pathol 22:278–284PubMedCrossRef
26.
Zurück zum Zitat Nakatome M, Matoba R, Ogura Y et al (2002) Detection of cardiomyocyte apoptosis in forensic autopsy cases. Int J Legal Med 116:17–21PubMedCrossRef Nakatome M, Matoba R, Ogura Y et al (2002) Detection of cardiomyocyte apoptosis in forensic autopsy cases. Int J Legal Med 116:17–21PubMedCrossRef
27.
Zurück zum Zitat Matsushita T, Takamatsu T (1997) Ischaemia-induced temporal expression of connexin43 in rat heart. Virchows Arch 431:453–458PubMedCrossRef Matsushita T, Takamatsu T (1997) Ischaemia-induced temporal expression of connexin43 in rat heart. Virchows Arch 431:453–458PubMedCrossRef
28.
Zurück zum Zitat Hatanaka K, Kawata H, Toyofuku T et al (2004) Down-regulation of connexin43 in early myocardial ischemia and protective effect by ischemic preconditioning in rat hearts in vivo. Jpn Heart J 45:1007–1019PubMedCrossRef Hatanaka K, Kawata H, Toyofuku T et al (2004) Down-regulation of connexin43 in early myocardial ischemia and protective effect by ischemic preconditioning in rat hearts in vivo. Jpn Heart J 45:1007–1019PubMedCrossRef
29.
Zurück zum Zitat Shaulian E, Karin M (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol 4(5):E131–E136PubMedCrossRef Shaulian E, Karin M (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol 4(5):E131–E136PubMedCrossRef
30.
Zurück zum Zitat Harpster MH, Bandyopadhyay S, Thomas DP et al (2006) Earliest changes in the left ventricular transcriptome postmyocardial infarction. Mamm Genome 17:701–715PubMedCrossRef Harpster MH, Bandyopadhyay S, Thomas DP et al (2006) Earliest changes in the left ventricular transcriptome postmyocardial infarction. Mamm Genome 17:701–715PubMedCrossRef
31.
Zurück zum Zitat Vargas SO, Sampson BA, Schoen FJ (1999) Pathologic detection of early myocardial infarction: a critical review of the evolution and usefulness of modern techniques. Mod Pathol 12:635–645PubMed Vargas SO, Sampson BA, Schoen FJ (1999) Pathologic detection of early myocardial infarction: a critical review of the evolution and usefulness of modern techniques. Mod Pathol 12:635–645PubMed
32.
Zurück zum Zitat Kavsak PA, MacRae AR, Newman AM et al (2007) Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction. Clin Chem Acta 380(1–2):213–216CrossRef Kavsak PA, MacRae AR, Newman AM et al (2007) Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction. Clin Chem Acta 380(1–2):213–216CrossRef
33.
Zurück zum Zitat Brinkmann B, Sepulchre MA, Fechner G (1993) The application of selected histochemical and immunohistochemical markers and procedures to the diagnosis of early myocardial damage. Int J Legal Med 106(3):135–141PubMedCrossRef Brinkmann B, Sepulchre MA, Fechner G (1993) The application of selected histochemical and immunohistochemical markers and procedures to the diagnosis of early myocardial damage. Int J Legal Med 106(3):135–141PubMedCrossRef
34.
Zurück zum Zitat Leadbeatter S, Wawman HM, Jasani B (1989) Immunocytochemical diagnosis of early myocardial ischaemic/hypoxic damage. Forensic Sci Int 40(2):171–180PubMedCrossRef Leadbeatter S, Wawman HM, Jasani B (1989) Immunocytochemical diagnosis of early myocardial ischaemic/hypoxic damage. Forensic Sci Int 40(2):171–180PubMedCrossRef
35.
Zurück zum Zitat Collinson PO, Gaze DC (2007) Biomarkers of cardiovascular damage. Med Princ Pract 16(4):247–261PubMedCrossRef Collinson PO, Gaze DC (2007) Biomarkers of cardiovascular damage. Med Princ Pract 16(4):247–261PubMedCrossRef
Metadaten
Titel
Early markers of myocardial ischemia: from the experimental model to forensic pathology cases of sudden cardiac death
verfasst von
Sara Sabatasso
Milena Moretti
Patrice Mangin
Tony Fracasso
Publikationsdatum
11.05.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
International Journal of Legal Medicine / Ausgabe 1/2018
Print ISSN: 0937-9827
Elektronische ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-017-1605-7

Weitere Artikel der Ausgabe 1/2018

International Journal of Legal Medicine 1/2018 Zur Ausgabe

Neu im Fachgebiet Rechtsmedizin